Han Xu, Ph.D.
The University of Texas M.D. Anderson Cancer Center
|Titles & Positions|
|Institutional & Related Links|
|Grant ID: RR160097|
Recruitment of First-Time, Tenure-Track Faculty Members
The Broad Institute
September 14, 2016
One of the things that makes cancer cells so difficult to shut down are redundant regulatory mechanisms inside the cells. Targeting one gene with a pharmaceutical designed to kill the cell may not be enough to stop the cancer cell in its tracks, because another pathway may take over. Multiple redundant systems form complex networks.
“It may be necessary to perturb several interconnected cancer regulators in order to shut down the cancer cell,” says Han Xu, assistant professor in the Department of Epigenetics and Molecular Carcinogenesis at the University of Texas MD Anderson Cancer Center, Science Park campus, in Smithville. Xu was recruited from the Broad Institute of MIT and Harvard with the help of a First Time Tenure Track Award from CPRIT.